SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will participate in the 13^th Annual Roth Technology Conference.

The conference is being held in New York City on November 19-20, 2024. Cibus is available for meetings on both days of the conference. Conference attendees should reach out to the Company or their conference host representative to schedule.

About Cibus

Cibus is a leading independent plant trait company that develops and licenses plant traits to seed companies for royalties. Cibus is not a seed company, but rather a technology company that uses its proprietary gene editing technology to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus’ strategy is focused on commercializing productivity traits for the world’s major row crops with large acreage such as: canola, rice, soybean, corn and wheat. The Company targets traits that help manage farmers’ seed productivity, economics and sustainability challenges such as weeds, disease, and insects. The United Nations estimates that the impacts from these challenges cost the global economy approximately $300 billion annually. Cibus has a current portfolio of six traits, three of which are in commercial development and four of which are multi-crop traits associated with weed management and disease, including Sclerotinia resistance and a new weed management trait which are in advanced greenhouse and field trial stages.

CIBUS CONTACTS:

INVESTOR RELATIONS
Karen Troeber
This email address is being protected from spambots. You need JavaScript enabled to view it.
858-450-2636

Jeff Sonnek – ICR
This email address is being protected from spambots. You need JavaScript enabled to view it. 

MEDIA RELATIONS
This email address is being protected from spambots. You need JavaScript enabled to view it.

Colin Sanford
This email address is being protected from spambots. You need JavaScript enabled to view it. 
203-918-4347